Sundrug Co.,Ltd. (TYO:9989)

Sundrug Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Sundrug stock has a consensus rating of "Buy" and an average price target of ¥4,660. The average 1-year stock price forecast is 18.76% higher than the current stock price, while the lowest is ¥3,820 (-2.65%) and the highest is ¥5,600 (+42.71%).

Price Target: ¥4,660 (+18.76%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	¥3,820	¥4,660	¥4,800	¥5,600
Change	-2.65%	+18.76%	+22.32%	+42.71%

Analyst Ratings

The average analyst rating for Sundrug stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Oct '26	Nov '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	2	2
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst J.P. Morgan No rating	J.P. Morgan	Hold Maintains ¥4,100	Hold	Maintains	¥4,100	+4.49%	Nov 4, 2026
Unknown Analyst UBS No rating	UBS	Hold Maintains ¥4,030 → ¥3,820	Hold	Maintains	¥4,030 → ¥3,820	-2.65%	Oct 6, 2026
Unknown Analyst Bank of America Securities No rating	Bank of America Securities	Buy Maintains ¥4,600	Buy	Maintains	¥4,600	+17.23%	Aug 17, 2026
Unknown Analyst SMBC Nikko No rating	SMBC Nikko	Hold Maintains ¥4,200	Hold	Maintains	¥4,200	+7.03%	Jun 3, 2026
Unknown Analyst Mizuho Securities No rating	Mizuho Securities	Buy Maintains ¥5,100	Buy	Maintains	¥5,100	+29.97%	May 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

893.14B

Increased by 6.01%

from 842.51B

Revenue Next Year

947.60B

Increased by 6.10%

from 893.14B

EPS This Year

282.50

Increased by 5.27%

from 268.36

EPS Next Year

302.38

Increased by 7.04%

from 282.50

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	648.73B	690.46B	751.78B	801.81B	842.51B	893.14B
Revenue Growth	2.27%	6.43%	8.88%	6.65%	5.08%	6.01%
Gross Profit	156.51B	171.95B	189.32B	204.09B	216.17B	228.59B
Gross Margin	24.12%	24.90%	25.18%	25.45%	25.66%	25.59%
Operating Income	34.05B	37.45B	41.00B	44.50B	46.83B	49.84B
Net Income	23.85B	25.70B	29.13B	30.75B	31.39B	33.01B
EPS	204.01	219.82	249.06	262.90	268.36	282.50
EPS Growth	-5.83%	7.75%	13.30%	5.56%	2.07%	5.27%
Forward PE	13.16	16.01	18.06	15.39	13.44	13.89
Dividend / Share	71.00	100.00	114.00	130.00	131.00	137.43
Dividend Growth	1.43%	40.85%	14.00%	14.04%	0.77%	4.91%
Free Cash Flow	-	-	-	-	12.96B	17.18B
No. Analysts	-	-	-	-	-	7

Financial currency is JPY.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	904.5B
Avg	893.1B
Low	876.0B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	7.4%
Avg	6.0%
Low	4.0%

EPS Forecast

Chart

EPS	2027	2028	2029
High	294.90
Avg	282.50
Low	272.69

EPS Growth

EPS Growth	2027	2028	2029
High	9.9%
Avg	5.3%
Low	1.6%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Nov 4, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Data Sources Report a data error